• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中的轻度认知障碍:临床综述。

Mild cognitive impairment in primary care: a clinical review.

机构信息

Department of Family Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Department of Family Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Postgrad Med J. 2018 Nov;94(1117):647-652. doi: 10.1136/postgradmedj-2018-136035. Epub 2018 Nov 5.

DOI:10.1136/postgradmedj-2018-136035
PMID:30397003
Abstract

Dementia is projected to become a global health priority but often not diagnosed in its earlier preclinical stage which is mild cognitive impairment (MCI). MCI is generally referred as a transition state between normal cognition and Alzheimer's disease. Primary care physicians play an important role in its early diagnosis and identification of patients most likely to progress to Alzheimer's disease while offering evidenced-based interventions that may reverse or halt the progression to further cognitive impairment. The aim of this review is to introduce the concept of MCI in primary care through a case-based clinical review. We discuss the case of a patient with MCI and provide an evidence-based framework for assessment, early recognition and management of MCI while addressing associated risk factors, neuropsychiatric symptoms and prognosis.

摘要

痴呆症预计将成为全球卫生重点,但在其早期临床前阶段(即轻度认知障碍,MCI)往往未被诊断出来。MCI 通常被认为是正常认知和阿尔茨海默病之间的过渡状态。初级保健医生在其早期诊断和识别最有可能进展为阿尔茨海默病的患者方面发挥着重要作用,同时提供基于证据的干预措施,这些措施可能会逆转或阻止认知障碍的进一步进展。本综述的目的是通过基于案例的临床回顾,在初级保健中介绍 MCI 的概念。我们讨论了一位 MCI 患者的病例,并提供了一个基于证据的评估、早期识别和管理 MCI 的框架,同时解决了相关的危险因素、神经精神症状和预后。

相似文献

1
Mild cognitive impairment in primary care: a clinical review.基层医疗中的轻度认知障碍:临床综述。
Postgrad Med J. 2018 Nov;94(1117):647-652. doi: 10.1136/postgradmedj-2018-136035. Epub 2018 Nov 5.
2
Mild cognitive impairment and dementia in primary care: the value of medical history.初级保健中的轻度认知障碍和痴呆:病史的价值。
Fam Pract. 2011 Aug;28(4):385-92. doi: 10.1093/fampra/cmr005. Epub 2011 Mar 14.
3
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对预测轻度认知障碍向阿尔茨海默病痴呆进展的增量价值。
Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.
4
Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.患者、护理伙伴和初级保健医生对轻度认知障碍和轻度阿尔茨海默病痴呆症管理的看法。
Postgrad Med. 2023 Jun;135(5):530-538. doi: 10.1080/00325481.2023.2217025. Epub 2023 May 29.
5
Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.抑郁症状对轻度认知障碍亚型转化为阿尔茨海默病的影响:一项基于社区的纵向研究。
J Alzheimers Dis. 2016;51(2):405-15. doi: 10.3233/JAD-150603.
6
Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.蒙特利尔认知评估记忆指数评分(MoCA-MIS)作为从轻度认知障碍到阿尔茨海默病转化的预测指标。
J Am Geriatr Soc. 2014 Apr;62(4):679-84. doi: 10.1111/jgs.12742. Epub 2014 Mar 17.
7
Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.在一个早期富集的轻度认知障碍样本中,用于预测转化和认知衰退的认知标志物和生物标志物的不同强度。
J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.
8
Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.内侧颞叶萎缩的视觉评估作为轻度认知障碍向痴呆转化的临床标志物以及预测轻度认知障碍和轻度阿尔茨海默病患者病情进展的研究
Dement Geriatr Cogn Disord. 2017;44(1-2):12-24. doi: 10.1159/000477342. Epub 2017 Jun 15.
9
Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis.神经心理学测量在预测老年人从轻度认知障碍到阿尔茨海默病型痴呆的进展中的作用:系统评价和荟萃分析。
Neuropsychol Rev. 2017 Dec;27(4):328-353. doi: 10.1007/s11065-017-9361-5. Epub 2017 Oct 10.
10
Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China.中国大陆社区老年居民轻度认知障碍结局的多状态马尔可夫模型。
Int Psychogeriatr. 2013 May;25(5):797-804. doi: 10.1017/S1041610212002220. Epub 2013 Jan 3.

引用本文的文献

1
Cytokine expression profile in the human brain of older adults.老年人人类大脑中的细胞因子表达谱。
bioRxiv. 2025 Jun 4:2025.06.02.657444. doi: 10.1101/2025.06.02.657444.
2
Assessment of Cognitive Functions in Multimorbid Patients in Lithuanian Primary Care Settings: A Cross-Sectional Study Using MMSE and LT-GPCOG.立陶宛初级保健机构中多病患者认知功能的评估:一项使用简易精神状态检查表(MMSE)和立陶宛全科医生认知功能问卷(LT-GPCOG)的横断面研究
Medicina (Kaunas). 2025 Jan 14;61(1):122. doi: 10.3390/medicina61010122.
3
Effect of Mediterranean Dietary Pattern on Cognitive Status in Community-Dwelling Older Adults.
地中海饮食模式对社区居住老年人认知状况的影响。
Nutrients. 2023 Sep 8;15(18):3911. doi: 10.3390/nu15183911.
4
Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial.益肾防衰颗粒治疗老年 MCI 患者的有效性和安全性:一项多中心、随机、双盲、平行分组、对照试验的研究方案。
BMC Complement Med Ther. 2023 Apr 3;23(1):101. doi: 10.1186/s12906-023-03940-x.
5
Challenges in detecting and managing mild cognitive impairment in primary care: a focus group study in Shanghai, China.在中国上海进行的一项焦点小组研究:初级保健中轻度认知障碍的检测和管理挑战。
BMJ Open. 2022 Sep 20;12(9):e062240. doi: 10.1136/bmjopen-2022-062240.
6
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.实用建议以实现及时、准确诊断症状性阿尔茨海默病(MCI 和痴呆):综述与综合。
J Intern Med. 2021 Aug;290(2):310-334. doi: 10.1111/joim.13244. Epub 2021 Mar 31.
7
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.种族差异与阿尔茨海默病专家的相遇有关,与分子成像和痴呆症药物的使用有关:使用 i2b2 进行的全企业分析。
J Alzheimers Dis. 2021;79(2):543-557. doi: 10.3233/JAD-200796.